Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul-Aug;14(4):303-310.
doi: 10.1016/j.dsx.2020.04.004. Epub 2020 Apr 9.

Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations

Awadhesh Kumar Singh  1 , Ritesh Gupta  2 , Amerta Ghosh  2 , Anoop Misra  3
Affiliations
Review

Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations

Awadhesh Kumar Singh et al. Diabetes Metab Syndr. 2020 Jul-Aug.

Abstract

Background and aims: High prevalence of diabetes makes it an important comorbidity in patients with COVID-19. We sought to review and analyze the data regarding the association between diabetes and COVID-19, pathophysiology of the disease in diabetes and management of patients with diabetes who develop COVID-19 infection.

Methods: PubMed database and Google Scholar were searched using the key terms 'COVID-19', 'SARS-CoV-2', 'diabetes', 'antidiabetic therapy' up to April 2, 2020. Full texts of the retrieved articles were accessed.

Results: There is evidence of increased incidence and severity of COVID-19 in patients with diabetes. COVID-19 could have effect on the pathophysiology of diabetes. Blood glucose control is important not only for patients who are infected with COVID-19, but also for those without the disease. Innovations like telemedicine are useful to treat patients with diabetes in today's times.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest We hereby declare that we have no conflict of interest related to this article.

Figures

Fig. 1
Fig. 1
Prevalence (%) of severe vs. non-severe COVID-19 in patients with diabetes.
Fig. 2
Fig. 2
Prevalence (%) of non-survivor vs. survivor in patients with COVID-19 with diabetes.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 73 https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...
    1. Gupta R., Ghosh A., Singh A.K., Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020 Mar 10;14(3):211–212. doi: 10.1016/j.dsx.2020.03.002. - DOI - PMC - PubMed
    1. Akbar D.H. Bacterial pneumonia: comparison between diabetics and non-dia-betics. Acta Diabetol. 2001;38:77–82. - PubMed
    1. Yang J.K., Feng Y., Yuan M.Y., Yuan S.Y., Fu H.J., Wu B.Y. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med. 2006;23(6):623–628. - PubMed
    1. Allard R., Leclerc P., Tremblay C., Tannenbaum T.N. Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care. 2010;33(7):1491–1493. - PMC - PubMed

MeSH terms